19 research outputs found
Validation of the Italian version of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale.
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson's disease.
OBJECTIVES: To explore the impact of sex and age on relationship between prodromal constipation and disease phenotype in Parkinson's disease at early stages. METHODS: A total of 385 Parkinson's disease patients from the PRIAMO study were classified according to the presence of prodromal constipation and followed for 24Â months. Multivariable mixed-effect models were applied. All analyses were performed separately for sex (64.1% men) and median age (different by sex: 67Â years-old in men and 68Â years-old in women). RESULTS: As for sex, prodromal constipation was associated with greater odds of attention/memory complaints and apathy symptoms in women only. As for age, prodromal constipation was associated with lower cognitive and higher apathy scores in older patients only. CONCLUSIONS: Prodromal constipation anticipates lower cognitive performances and more severe apathy since the earliest stages in women and older patients. Sex- and age-related heterogeneity of prodromal markers of Parkinson's disease may impact disease phenotype
Effetto dellâambiente collinare sulla qualitĂ fisico-chimica e igienico-sanitaria del latte destinato alla trasformazione in Parmigiano-Reggiano.
Effetti della consistenza degli allevamenti su qualitĂ chimica e igienico-sanitaria del latte destinato alla trasformazione in Parmigiano-Reggiano.
Effect of pedoclimatic conditions on physico-chemical characteristics, hygienic-sanitary quality and coagulation properties of milk for Parmigiano-Reggiano cheese.
The aim of this study was to compare the quality of milk produced in different pedoclimatic zones (hill and plain) des-tined to the production of Parmigiano-Reggiano cheese. The study was carried out on 4,996 herd milk samples (1,464 from 53 herds located in hill areas and 3,532 from 97 herds located in the plains) collected in the province of Reggio Emi-lia. The following parameters were determined for each milk sample: fat, protein, titratable acidity, total bacterial count, somatic cells, coliforms bacteria, Clostridia spores and rennet coagulation properties. Milk produced by hill herds was characterized by higher fat content (3.51 vs 3.47 g/100g; Pâ€0.05) and lower total bacterial count (58,242 vs 66,833 CFU/mL; Pâ€0.001), somatic cells (285,369 vs 309,660 cells/mL; Pâ€0.01) and coliforms bacteria (1,198 vs 1,334 CFU/mL; Pâ€0.001) compared to milk produced in plain herds. Moreover, milk produced in hill herds showed a lower per-cent of samples with anomalous coagulation attitude (0.13 vs 0.68%; Pâ€0.05) and a lower rate of samples contaminated by Clostridia spores (16.05 vs 19.71%; Pâ€0.01) than milk produced in plain herds
Effetti della consistenza degli allevamenti su qualitĂ chimica e igienico-sanitaria del latte destinato alla trasformazione in Parmigiano-Reggiano
Effect of herd size on physico-chemical characteristics, hygienic-sanitary quality and coagulation properties of milk for Parmigiano-Reggiano cheese.
Validation of the Italian version of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale
Validation of the Italian version of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale
The PRIAMO study: background, methods and recruitment
PRIAMO (PaRkinson And non Motor symptOms) is an epidemiology study aimed to assess the prevalence and incidence of non-motor symptoms (NMS) in patients with parkinsonism. PRIAMO consists of two phases: (1) a transversal assessment of the prevalence of NMS and (2) a longitudinal observation with two follow-up visits at 12 and 24 months to establish the incidence of NMS. A secondary aim of PRIAMO is to study the relationship between NMS and quality of life. Patients with parkinsonism have been evaluated in 59 Neurology Centres widely distributed throughout Italy. PRIAMO has analysed a total of 1307 patients (out of 1325 initially enrolled). We expect that PRIAMO will substantially help to quantify the burden of NMS in patients with parkinsonism